<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="84481">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02005445</url>
  </required_header>
  <id_info>
    <org_study_id>F1351-P</org_study_id>
    <nct_id>NCT02005445</nct_id>
  </id_info>
  <brief_title>Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation</brief_title>
  <official_title>Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized clinical trial in U.S. Veterans to evaluate the impact of treatment for
      obstructive sleep apnea (OSA) on the effectiveness of cardiac rehabilitation, including
      impact on exercise capacity, disability, and quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep apnea (OSA) is a highly prevalent condition in patients with coronary
      heart disease and is associated with impaired exercise performance, functional limitation
      and reduced health-related quality of life. The investigators hypothesize that
      identification and treatment of OSA in patients undergoing cardiac rehabilitation will
      improve the response to rehabilitation. The proposed study will test this hypothesis using a
      parallel group, randomized, clinical trial comparing OSA treatment with continuous positive
      airway pressure (CPAP) to an educational control group in patients undergoing cardiac
      rehabilitation who screen positive for previously undiagnosed OSA.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2014</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional status</measure>
    <time_frame>12 weeks</time_frame>
    <description>Functional status as measured by the WHO Disability Assessment Scale 2 questionnaire</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous positive airway pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HLSE</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Healthy living and sleep education</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Continuous positive airway pressure</description>
    <arm_group_label>CPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HLSE</intervention_name>
    <description>Healthy living and sleep education</description>
    <arm_group_label>HLSE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Veterans referred for cardiac rehabilitation at the VA Boston Healthcare System.

          -  Moderate to severe OSA (AHI &gt;15) on home sleep testing.

        Exclusion Criteria:

          -  Dangerous levels of sleepiness (Epworth Sleepiness Scale score &gt;16 or a report of
             falling asleep at the wheel of a car within the past 2 years).

          -  Physical limitation precluding exercise testing.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel J Gottlieb, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel J Gottlieb, MD MPH</last_name>
    <phone>(857) 203-6375</phone>
    <email>daniel.gottlieb@va.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel J Gottlieb, MD MPH</last_name>
      <phone>857-203-6375</phone>
      <email>daniel.gottlieb@va.gov</email>
    </contact>
    <investigator>
      <last_name>Daniel J Gottlieb, MD MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 4, 2017</lastchanged_date>
  <firstreceived_date>December 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Coronary heart disease</keyword>
  <keyword>Cardiac rehabilitation</keyword>
  <keyword>Cardiopulmonary exercise testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
